Characterization of a multidrug-resistant Klebsiella pneumoniae ST607-K25 clone responsible for a nosocomial outbreak in a neonatal intensive care unit.


Journal

Journal of medical microbiology
ISSN: 1473-5644
Titre abrégé: J Med Microbiol
Pays: England
ID NLM: 0224131

Informations de publication

Date de publication:
Jan 2019
Historique:
pubmed: 7 12 2018
medline: 23 1 2019
entrez: 4 12 2018
Statut: ppublish

Résumé

Multidrug-resistant Klebsiella pneumoniae strains are regularly involved in hospital outbreaks. This study describes an ESBL-producing K. pneumoniae clone (ST607-K25) responsible for a nosocomial outbreak in a neonatal intensive care unit. Fourteen strains isolated from 13 patients were included. Antimicrobial susceptibility testing was performed by the agar diffusion method. A clonal link was first investigated by fingerprinting (ERIC-PCR and REP-PCR) then confirmed by MLST. Characterization was performed by molecular detection and identification of several drug resistance and virulence determinants. All strains expressed the same antibiotype, combining ESBL production, fluoroquinolones and aminoglycoside resistance, except for one which remained susceptible to fluoroquinolones. Fingerprinting methods confirmed the clonal link and MLST identified a ST607 clone. Molecular investigations revealed: (I) genes encoding for two narrow-spectrum beta-lactamases (SHV-1 and TEM-1) and an ESBL (CTX-M-15); (II) absence of any chromosomal mutation in quinolone resistance-determining- regions (QRDR) of gyrA/gyrB and parC/parE genes; (III) genes encoding for three plasmid-mediated quinolone-resistance (PMQR) determinants: oqxAB (14/14), aac(6')-Ib-cr (14/14) and qnrB (13/14); (IV) production of a K25 capsule; and (V) carriage of three genes encoding for virulence factors: mrkD (type 3 fimbriae) (14/14), ybts (yersiniabactin) (12/14) and entB (enterobactin) (14/14). We described a multidrug-resistant Kp ST607 clone responsible for a nosocomial outbreak in vulnerable and premature newborns. Molecular investigations allowed us to identify several resistance factors responsible for ESBL production (CTX-M-15) and quinolone resistance (three PMQR determinants). The detection of a gene (ybtS) belonging to the high-pathogenicity island yersiniabactin could partly explain its high colonization and diffusion potential.

Identifiants

pubmed: 30507374
doi: 10.1099/jmm.0.000884
doi:

Substances chimiques

Aminoglycosides 0
Anti-Bacterial Agents 0
Bacterial Proteins 0
Fluoroquinolones 0
beta-Lactamases EC 3.5.2.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

67-76

Auteurs

F Peltier (F)

1​Department of Bacteriology, Amiens-Picardie University Hospital, Amiens, France.
2​Microbiology Research Unit, AGIR -EA4294, Jules Verne University of Picardie, Amiens, France.

M Choquet (M)

1​Department of Bacteriology, Amiens-Picardie University Hospital, Amiens, France.
2​Microbiology Research Unit, AGIR -EA4294, Jules Verne University of Picardie, Amiens, France.

V Decroix (V)

1​Department of Bacteriology, Amiens-Picardie University Hospital, Amiens, France.
2​Microbiology Research Unit, AGIR -EA4294, Jules Verne University of Picardie, Amiens, France.

C C Adjidé (CC)

3​Nosocomial Infection Department, Amiens-Picardie University Hospital, Amiens, France.

S Castelain (S)

1​Department of Bacteriology, Amiens-Picardie University Hospital, Amiens, France.
2​Microbiology Research Unit, AGIR -EA4294, Jules Verne University of Picardie, Amiens, France.

R Guiheneuf (R)

1​Department of Bacteriology, Amiens-Picardie University Hospital, Amiens, France.
2​Microbiology Research Unit, AGIR -EA4294, Jules Verne University of Picardie, Amiens, France.

E Pluquet (E)

1​Department of Bacteriology, Amiens-Picardie University Hospital, Amiens, France.
2​Microbiology Research Unit, AGIR -EA4294, Jules Verne University of Picardie, Amiens, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH